Learn about side effects, uses, and more of Verzenio (abemaciclib). It's a prescription tablet that treats certain kinds of breast cancer in adults.

DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a targeted treatment known as a CDK4/6 inhibitor. The drug is a non ...

How Does Verzenio Work for Metastatic Breast Cancer? Verzenio is a type of medicine called a kinase inhibitor. Kinases are enzymes in the body that can send and receive signals to help your cells ...

Verzenio remains the only drug in the CDK4/6 class to be approved for adjuvant use in early breast cancer, which has helped it to buoyant sales growth, up 84% to nearly $2.5 billion last year.

Verzenio may cause serious side effects. The list below may not include all possible serious side effects of the drug. For more information, you can refer to the drug’s prescribing information ...

Verzenio is an oral tablet taken twice daily and available in strengths of 50 mg, 100 mg, 150 mg, and 200 mg. Discovered and developed by Lilly researchers, Verzenio was first approved in 2017 and ...

It looks like Eli Lilly’s oral selective estrogen receptor degrader (SERD) imlunestrant may need some extra help to reach a broad patient population with ER-positive, HER2-negative breast cancer.

How Do I Take Verzenio for Early Breast Cancer? Verzenio is taken as a tablet that you will swallow. You take Verzenio twice a day, and you can take it with or without food. You should try to take ...

DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a targeted treatment known as a CDK4/6 inhibitor. The drug is a ...